Ropivacaine Injection Shortage
Last Updated: February 10, 2025
Status: Current
Products Affected - Description
-
- Ropivacaine injection, Eugia US, 10 mg/mL, 10 mL vial, 25 count, NDC 55150-0200-10
- Ropivacaine injection, Hikma, 2 mg/mL, 20 mL vial, 10 count, NDC 00143-9263-10
Reason for the Shortage
-
- Akorn ceased operations in February 2023.
- Amneal has ropivacaine available.
- Baxter has ropivacaine available.
- Eugia has ropivacaine on shortage due to increased demand.
- Fresenius Kabi has ropivacaine available. Multiple presentations were discontinued in mid-2024.
- Hikma did not provide a reason for the shortage.
- Pfizer discontinued ropivacaine in August 2022.
- Somerset Therapeutics has ropivacaine available.
- Sagent has ropivacaine available.
- Viatris has ropivacaine available.
Available Products
-
- Naropin injection, Amneal, 2 mg/mL, 100 mL premixed bag, 24 count, NDC 70121-1732-09
- Naropin injection, Amneal, 2 mg/mL, 200 mL premixed bag, 24 count, NDC 70121-1733-09
- Naropin injection, Amneal, 5 mg/mL, 100 mL premixed bag, 12 count, NDC 70121-1734-03
- Naropin injection, Baxter, 2 mg/mL, 100 mL premixed bag, 10 count, NDC 43066-0152-10
- Naropin injection, Baxter, 2 mg/mL, 200 mL premixed bag, 10 count, NDC 43066-0154-10
- Naropin injection, Fresenius Kabi, 10 mg/mL, 10 mL vial, 25 count, NDC 63323-0288-11
- Naropin injection, Fresenius Kabi, 10 mg/mL, 20 mL vial, 25 count, NDC 63323-0288-21
- Naropin injection, Fresenius Kabi, 2 mg/mL, 10 mL vial, 25 count, NDC 63323-0285-13
- Naropin injection, Fresenius Kabi, 2 mg/mL, 100 mL infusion bottle, 1 count, NDC 63323-0285-65
- Naropin injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 25 count, NDC 63323-0285-23
- Naropin injection, Fresenius Kabi, 2 mg/mL, 200 mL infusion bottle, 1 count, NDC 63323-0285-64
- Naropin injection, Fresenius Kabi, 5 mg/mL, 100 mL infusion bottle, 1 count, NDC 63323-0286-00
- Naropin injection, Fresenius Kabi, 5 mg/mL, 20 mL vial, 25 count, NDC 63323-0286-23
- Naropin injection, Fresenius Kabi, 5 mg/mL, 200 mL infusion bottle, 1 count, NDC 63323-0286-63
- Naropin injection, Fresenius Kabi, 5 mg/mL, 30 mL vial, 25 count, NDC 63323-0286-35
- Naropin injection, Fresenius Kabi, 7.5 mg/mL, 20 mL Steripak plastic ampule, 5 count, NDC 63323-0287-20
- Naropin injection, Fresenius Kabi, 7.5 mg/mL, 20 mL vial, 25 count, NDC 63323-0287-21
- Ropivacaine injection, Baxter, 10 mg/mL, 20 mL vial, 10 count, NDC 43066-0027-10
- Ropivacaine injection, Baxter, 2 mg/mL, 20 mL vial, 10 count, NDC 43066-0015-10
- Ropivacaine injection, Baxter, 5 mg/mL, 20 mL vial, 10 count, NDC 43066-0019-10
- Ropivacaine injection, Baxter, 5 mg/mL, 30 mL vial, 10 count, NDC 43066-0023-10
- Ropivacaine injection, Eugia US, 10 mg/mL, 20 mL vial, 25 count, NDC 55150-0201-20
- Ropivacaine injection, Eugia US, 2 mg/mL, 100 mL infusion bottle, 25 count, NDC 55150-0196-99
- Ropivacaine injection, Eugia US, 2 mg/mL, 20 mL vial, 25 count, NDC 55150-0195-20
- Ropivacaine injection, Eugia US, 5 mg/mL, 20 mL vial, 25 count, NDC 55150-0197-20
- Ropivacaine injection, Eugia US, 5 mg/mL, 30 mL vial, 25 count, NDC 55150-0198-30
- Ropivacaine injection, Eugia US, 7.5 mg/mL, 20 mL vial, 25 count, NDC 55150-0199-20
- Ropivacaine injection, Mylan (Viatris), 2 mg/mL, 100 mL premixed bag, 10 count, NDC 67457-0798-99
- Ropivacaine injection, Mylan (Viatris), 2 mg/mL, 200 mL premixed bag, 10 count, NDC 67457-0799-99
- Ropivacaine injection, Sagent, 2 mg/mL, 100 mL premixed bag, 10 count, NDC 25021-0671-82
- Ropivacaine injection, Sagent, 2 mg/mL, 200 mL premixed bag, 10 count, NDC 25021-0671-87
- Ropivacaine injection, Sagent, 5 mg/mL, 100 mL premixed bag, 10 count, NDC 25021-0652-82
- Ropivacaine injection, Sagent, 5 mg/mL, 200 mL premixed bag, 10 count, NDC 25021-0652-87
- Ropivacaine injection, Somerset Therapeutics LLC, 10 mg/mL, 20 mL vial, 10 count, NDC 70069-0067-10
- Ropivacaine injection, Somerset Therapeutics LLC, 10 mg/mL, 20 mL vial, 25 count, NDC 70069-0067-25
- Ropivacaine injection, Somerset Therapeutics LLC, 2 mg/mL, 10 mL vial, 10 count, NDC 70069-0061-10
- Ropivacaine injection, Somerset Therapeutics LLC, 2 mg/mL, 10 mL vial, 25 count, NDC 70069-0061-25
- Ropivacaine injection, Somerset Therapeutics LLC, 2 mg/mL, 20 mL vial, 10 count, NDC 70069-0062-10
- Ropivacaine injection, Somerset Therapeutics LLC, 2 mg/mL, 20 mL vial, 25 count, NDC 70069-0062-25
- Ropivacaine injection, Somerset Therapeutics LLC, 5 mg/mL, 20 mL vial, 25 count, NDC 70069-0063-25
- Ropivacaine injection, Somerset Therapeutics LLC, 5 mg/mL, 30 mL vial, 1 count, NDC 70069-0064-01
- Ropivacaine injection, Somerset Therapeutics LLC, 5 mg/mL, 30 mL vial, 10 count, NDC 70069-0064-10
- Ropivacaine injection, Somerset Therapeutics LLC, 5 mg/mL, 30 mL vial, 25 count, NDC 70069-0064-25
Estimated Resupply Dates
-
- Eugia has ropivacaine 10 mg/mL 10 mL vials on back order and the company cannot estimate a release date.
- Hikma has ropivacaine 2 mg/mL 20 mL vials on back order and the company cannot estimate a release date.
Updated
Updated February 10, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 27, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.